Trial Outcomes & Findings for Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates (NCT NCT01519570)
NCT ID: NCT01519570
Last Updated: 2019-02-01
Results Overview
Six months after the intervention, a second EMR report was generated to determine the change in vaccination rate of both the intervention and control groups.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
2589 participants
Primary outcome timeframe
6 months
Results posted on
2019-02-01
Participant Flow
Participant milestones
| Measure |
An Informational Packet Regarding Shingles and the HZV
An informational packet regarding shingles and the HZV was sent to patients identified by the EMR: The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.
|
Standard Medical Care From Their Primary Care Physician
|
|---|---|---|
|
Overall Study
STARTED
|
500
|
2089
|
|
Overall Study
COMPLETED
|
500
|
2089
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
Baseline characteristics by cohort
| Measure |
An Informational Packet Regarding Shingles and the HZV
n=500 Participants
An informational packet regarding shingles and the HZV was sent to patients identified by the EMR: The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.
|
Standard Medical Care From Their Primary Care Physician
n=2089 Participants
|
Total
n=2589 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
500 Participants
n=5 Participants
|
2089 Participants
n=7 Participants
|
2589 Participants
n=5 Participants
|
|
Age, Continuous
|
72.1 years
STANDARD_DEVIATION 9.4 • n=5 Participants
|
73.1 years
STANDARD_DEVIATION 8.1 • n=7 Participants
|
72.8 years
STANDARD_DEVIATION 8.7 • n=5 Participants
|
|
Sex: Female, Male
Female
|
265 Participants
n=5 Participants
|
1174 Participants
n=7 Participants
|
1439 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
235 Participants
n=5 Participants
|
915 Participants
n=7 Participants
|
1150 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
500 participants
n=5 Participants
|
2089 participants
n=7 Participants
|
2589 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 6 monthsSix months after the intervention, a second EMR report was generated to determine the change in vaccination rate of both the intervention and control groups.
Outcome measures
| Measure |
An Informational Packet Regarding Shingles and the HZV
n=500 Participants
An informational packet regarding shingles and the HZV was sent to patients identified by the EMR: The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.
|
Standard Medical Care From Their Primary Care Physician
n=2089 Participants
|
|---|---|---|
|
Number of Participants Who Received the Herpes Zoster Vaccine
|
500 Participants
|
2089 Participants
|
SECONDARY outcome
Timeframe: 6 monthsDifference in vaccination rates between patients sent communications via US postal service (USPS) and those sent communications via electronic patient portal (EPP)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 monthsOutcome measures
Outcome data not reported
Adverse Events
An Informational Packet Regarding Shingles and the HZV
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Standard Medical Care From Their Primary Care Physician
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Stuart Beatty
The Ohio State University College of Pharmacy
Phone: 6146888466
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place